Verification registerBio, Health & Neuro
Living definition
What is Suzetrigine (Journavx / VX-548)?
Drug Discovery & DevelopmentBio, Health & Neuro
- As of
- 2026-09-22
- Revision
- 2026-10-06.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Suzetrigine (Journavx / VX-548) is a non-opioid analgesic that selectively blocks the NaV1.8 sodium channel in peripheral pain-signalling neurons, treating acute pain without acting on opioid receptors in the brain.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-22, verified readiness is 72 (claimed 78, reported 78, gap 6) — Growing evidence strength; current signals suggest Adopt with guardrails.
The readiness fact belongs to the canonical Readiness Verdict for Suzetrigine (Journavx / VX-548).
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06